Stryker Said to Be in Talks on Boston Scientific Unit

Stryker Corp., a maker of artificial hips and knees, is in advanced talks to buy Boston Scientific Corp.’s pain-management device unit for about $1.5 billion, said three people with knowledge of the transaction.

An agreement for the business, also called the neuromodulation unit, may be announced next week, said the people, who declined to be identified because the talks are private. Stryker would probably pay all cash, and the deal may be valued at $1.4 billion to $1.5 billion, the people said.